Accuracy of the bleeding risk tool among BMI and anticoagulant groups
| AUC | Rating | |
|---|---|---|
| Overall | ||
| Bivalirudin | 0.63 | Poor |
| With GPI | 0.50 | Fail |
| Without | 0.64 | Poor |
| Heparin | 0.70 | Poor |
| With GPI | 0.65 | Poor |
| Without | 0.71 | Fair |
| GPI | 0.64 | Poor |
| Low BMI (0.67) | ||
| Bivalirudin | 0.56 | Fail |
| With GPI | 0.35 | Fail |
| Without | 0.59 | Fail |
| Heparin | 0.68 | Poor |
| With GPI | 0.66 | Poor |
| Without | 0.66 | Poor |
| GPI | 0.64 | Poor |
| High BMI (0.70) | ||
| Bivalirudin | 0.65 | Poor |
| With GPI | 0.54 | Fail |
| Without | 0.66 | Poor |
| Heparin | 0.70 | Poor |
| With GPI | 0.65 | Poor |
| Without | 0.71 | Poor |
AUC, area-under-the curve; BMI, body mass index; GIP, glycoprotein IIb/IIIa inhibitor.